In males with delayed puberty: Various dosage regimens have been used; some call for lower dosages initially with gradual increases as puberty progresses, with or without a decrease to maintenance levels. Other regimens call for higher dosage to induce pubertal changes and lower dosage for maintenance after puberty. The chronological and skeletal ages must be taken into consideration, both in determining the initial dose and in adjusting the dose. Dosage is within the range of 50 to 200 mg every 2 to 4 weeks for a limited duration, for example, 4 to 6 months. X-rays should be taken at appropriate intervals to determine the amount of bone maturation and skeletal development (see INDICATIONS AND USAGE and WARNINGS ).
North America, powered by strong demand for advanced TRT products in the ., dominates the global testosterone replacement market by accounting for almost % share in it. In fact, the . occupied about % of the North America market in 2015. Europe follows North America vis-à-vis market share. Other important markets are Asia Pacific, the Middle East and Africa (MEA), and Latin America. Asia Pacific is expected to exhibit speedy growth because of significantly higher healthcare investments. China and India hold out a solid potential for the TRT market. South Korea and Japan too will impact sales positively due to a growing population of geriatrics. In Latin America, Brazil is the primary TRT market with maximum share.
Dosage and duration of therapy with Delatestryl depends on the age, sex, diagnosis, patient's response to treatment, and appearance of adverse effects. Delatestryl may interact with blood thinners, or corticosteroids. Tell your doctor all medications and supplements you use. Delatestryl must not be used during pregnancy. It may harm a fetus. It is recommended that women use 2 forms of birth control (., condoms and birth control pills) while using this medication; consult your doctor. It is unknown if this drug passes into breast milk. It may affect milk production and it may harm a nursing infant. Breastfeeding while using this drug is not recommended.